Pages that link to "Q56073489"

The following pages link to Takashi Onda (Q56073489):

Displaying 41 items.

• Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives (Q28083801) (← links)
• Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy? (Q35234059) (← links)
• A rare case of recurrent ovarian cancer presenting as a round ligament metastasis (Q35576622) (← links)
• Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection. (Q36616507) (← links)
• Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix. (Q37222658) (← links)
• Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions (Q37909365) (← links)
• Serous adenocarcinoma of the uterine cervix: a clinicopathological study of 12 cases and a review of the literature. (Q37923698) (← links)
• The history of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG). (Q37926294) (← links)
• Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A). (Q38348194) (← links)
• Minimization of curative surgery for treatment of early cervical cancer: a review (Q38427477) (← links)
• Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity. (Q38811667) (← links)
• Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncol (Q39669919) (← links)
• Novel virtual cytological analysis for the detection of endometrial cancer cells using autoscan fluoromicroscopy (Q39785626) (← links)
• Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer (Q42599970) (← links)
• A case of vaginal clear cell adenocarcinoma complicated with congenital anomalies of the genitourinary tract and metanephric remnant without prenatal diethylstilbestrol exposure (Q42991821) (← links)
• Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA. (Q44625824) (← links)
• Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma. (Q44640484) (← links)
• Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study. (Q48559793) (← links)
• Versatile lotus petal flap for vulvoperineal reconstruction after gynecological ablative surgery. (Q51597329) (← links)
• Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix. (Q53170700) (← links)
• Clinical characteristics and outcomes of women with stage IV endometrial cancer. (Q53353041) (← links)
• Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation. (Q53398109) (← links)
• Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma. (Q54530132) (← links)
• Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata. (Q54784194) (← links)
• Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101) (Q64110340) (← links)
• Familial risk factors for a second primary malignancy in endometrial or ovarian carcinoma (Q70974612) (← links)
• Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy (Q71394593) (← links)
• CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker (Q73395765) (← links)
• Characterization of IgA response among women with incident HPV 16 infection (Q73733757) (← links)
• Prevalence of ovarian endometriosis in epithelial ovarian cancer (Q74256318) (← links)
• Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas (Q77815495) (← links)
• Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206 (Q79776209) (← links)
• Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602 (Q80656464) (← links)
• Cisplatin, paclitaxel and escalating doses of doxorubicin (TAP) in advanced ovarian cancer: a phase I trial (Q80825480) (← links)
• Surgical treatment for neuroendocrine carcinoma of the uterine cervix (Q81356871) (← links)
• Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma (Q81545686) (← links)
• Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206 (Q83268686) (← links)
• Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix (Q84574320) (← links)
• The optimal debulking after neoadjuvant chemotherapy in ovarian cancer: proposal based on interval look during upfront surgery setting treatment (Q84699471) (← links)
• Bifunctional roles of survivin-ΔEx3 and survivin-2B for susceptibility to apoptosis in endometrial carcinomas (Q87388333) (← links)
• Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial (Q90369145) (← links)